PARK2 can inhibit the JAK2/STAT3/VEGF signaling pathway, and also through association with other genes and protein–protein interactions, regulate the network of growth pathways, thus becoming a vital tumor suppressor. The gene discussed is PRKN; the disease is neoplasm.